Search
Feed aggregator
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq 4/26/2024
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty 4/26/2024
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline 4/26/2024
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement
GSK Sues Pfizer and BioNTech Over Alleged COVID-19 Patent Infringement 4/26/2024
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost 4/26/2024
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree
BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree 4/26/2024
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results 4/26/2024
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1
BMS to Cut 2,200 Jobs in $1.5B Restructuring as Opdivo Sales Drop in Q1 4/25/2024
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20% 4/25/2024
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy
Sanders Launches Probe of ‘Outrageously High Prices’ of Novo’s Ozempic, Wegovy 4/25/2024
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery 4/25/2024
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 4/25/2024
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier
FTC’s Noncompete Ban Makes Switching Biopharma Jobs Easier 4/25/2024
FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women
FDA Approves UTILITY’s New Antibiotic for Uncomplicated UTI in Women 4/25/2024
7 Types of Difficult Bosses and How to Deal With Them
7 Types of Difficult Bosses and How to Deal With Them 4/25/2024
Why Biopharma Companies Avoid Hiring People Who Need Visas
Why Biopharma Companies Avoid Hiring People Who Need Visas 4/25/2024
Where Do We Go From Here? The Future of Women's Health
Where Do We Go From Here? The Future of Women's Health 4/25/2024
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales 4/23/2024
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win 4/23/2024
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates 4/23/2024
World Pharma News
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
- A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
- Common gout drug may reduce risk of heart attack and stroke
- New nasal vaccine has potential to transform respiratory disease prevention
- MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs